Lab firm CEO retires, to be replaced by former AstraZeneca exec

Douglas VanOort has been CEO of NeoGenomics for 12 years.

  • By Business Observer Staff
  • | 3:39 p.m. February 26, 2021
Courtesy. Mark Mallon.
Courtesy. Mark Mallon.
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — Douglas VanOort, longtime CEO of oncology testing and global contract research services firm NeoGenomics, has announced his retirement from the CEO role, transitioning to executive chairman.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • April 2, 2026
Sarasota Doctors Hospital names new COO
  • April 2, 2026
Babcock Ranch shopping center gets refinance
  • April 2, 2026
Report: Childhood poverty pockets remain in region amid Florida decline
  • April 2, 2026
Hillsborough to spend $70M on stormwater drainage improvements

Sponsored Content